Skip to content
Connect AISign inSign up free
CVE-2023-38955Not scoredCWE-668

CVE-2023-38955: Zkteco Bioaccess Ivs vulnerability

Zkteco · Bioaccess Ivs

Affected: Zkteco Bioaccess Ivs · Exploitation: unlikely (under 1%)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

0.6%probability of exploitation in the next 30 days
49th percentile
050100

Higher than 49% of scored CVEs

Not scored yet. The CVE record carries no CVSS score.

DescriptionCVE.org

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas
Exploitation
Unlikely (under 1%). EPSS under 1%, or no score yet.
CISA KEV
Not listed
Public check
No public nuclei template
Vendor
Zkteco
Published
August 2023

CoverageNo articles yet

No CyberSIXT article names CVE-2023-38955 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.

References